Fructosamine or glycated haemoglobin as a measure of diabetic control?

J Allgrove1, B L Cockrill

  • 1East Birmingham Hospital.

Insights

Glycated haemoglobin A1c (HbA1c) and fructosamine are useful for monitoring pediatric diabetes. Fructosamine may serve as a valuable short-term indicator of disease progression or improvement.

Area of Science:

  • Clinical Chemistry
  • Pediatric Endocrinology
  • Diabetes Mellitus Management

Background:

  • Glycated haemoglobin A1c (HbA1c) and fructosamine are key biomarkers for diabetes monitoring.
  • Establishing pediatric-specific reference ranges for these markers is crucial for accurate assessment.
  • Understanding the correlation and utility of these markers in children is essential for effective diabetes care.

Purpose of the Study:

  • To establish normal ranges for HbA1c and fructosamine in children.
  • To investigate the correlation between HbA1c and fructosamine in diabetic children.
  • To evaluate the utility of fructosamine as a short-term indicator of diabetes control in children.

Main Methods:

  • Measurement of HbA1c, fructosamine, and total serum proteins in 30 normal and 61 diabetic children.
  • Analysis of correlation between HbA1c and fructosamine.
  • Longitudinal monitoring of HbA1c and fructosamine levels in a small cohort of patients with changing diabetes status.

Main Results:

  • Normal ranges for pediatric HbA1c (4.7-8.8%) and fructosamine (0.98-1.88 mmol/l) were similar to adult ranges, with no significant age-related differences.
  • A strong correlation between HbA1c and fructosamine was observed in diabetic children, but this diminished within normal ranges.
  • Fructosamine decay half-life was 16.5 days, compared to 28.7 days for HbA1c. Fructosamine levels reflected short-term glycemic changes, indicating improvement or deterioration.
  • Adjustment for total serum proteins did not alter fructosamine results.

Conclusions:

  • Fructosamine is not a direct substitute for HbA1c but can be a useful adjunct for short-term diabetes monitoring in children.
  • Monitoring fructosamine can help assess if a patient's condition is worsening or improving.
  • Integrating fructosamine testing into routine diabetes assessment, alongside occasional HbA1c testing, may offer cost savings and retain the benefits of both assays.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...